One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-146602
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 11 |
Affiliation: Cleveland Clinic, Royal Brisbane and Women's Hospital, Nkarta Therapeutics (United States), The University of Texas MD Anderson Cancer Center, Royal Prince Alfred Hospital, St Vincent's Hospital Sydney, Colorado Blood Cancer Institute, Sarah Cannon, Royal Melbourne Hospital, University of ChicagoA Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with B-Cell Malignancies
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
